Caesarean -Section Study Summary A total of 94 subjects were equally randomized into the active and placebo treatment groups in this double blind study. The primary measures were daily pain levels and medication use. In hospital pain scores were found to be equivalent across the two groups and averaged about 3.5 VAS points due to […]
View PostBioElectronics Announces FDA Market Clearance for Its Non-Opioid Postoperative Pain Therapy
FREDERICK, MD, July 01, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to announce that it has received market clearance from the United States Food and Drug Administration (US FDA) for its RecoveryRx® medical device, for the treatment of postoperative pain. Physicians are […]
View PostBioElectronics and B. Braun Medical Ltd Apply for Prescription Payment Clearance on the UK Drug Tariff
FREDERICK, MD. Feb 18, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that B. Braun has initiated the application for a listing of RecoveryRx® on the National Health Service (NHS) drug tariff (http://www.nhsbsa.nhs.uk/PrescriptionServices/4940.aspx).The UK drug tariff list establishes payment for prescription costs in the UK. “Orthopedic surgeons […]
View PostBioElectronics Device Alleviates Dental Surgical Trauma
New study shows RecoveryRx reduces pain and inflammation and accelerates healing FREDERICK, MD, USA, March 25, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Dr. Bartolomeo Operti MD, Chief of Anesthesia Department Day Hospital Section of Maria Adelaide Hospital and Dr. Tiziano Tealdo, Clinical Instructor at […]
View PostBioElectronics Researchers and Clinicians Support FDA’s Position to Reclassify Shortwave Medical Devices to Class II
FREDERICK, MD (February 27, 2014) – Medical device researchers and clinicians are optimistically supportive of the Food and Drug Administration’s decision last week to reclassify and rename electronic shortwave diathermy for many other uses, a decision that may improve access to safe, clinically tested medical devices that serve as alternatives to risky pain medications. Officials […]
View PostBioElectronics Applauds FDA Recommendation to Reclassify Shortwave Medical Devices to Class II
FDA’s Proposed Regulations Opens New US Markets FREDERICK, MD, USA, February 21, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of disposable drug-free healing pain therapy devices welcomed the FDA recommendations announced today in their Docket No. FDA-2012-N-0378, “Physical Medicine Devices; Reclassification and Renaming of Shortwave Diathermy for All Other Uses. “We are pleased […]
View PostPain Management Medical Journal Features BioElectronics’ Innovative Pain Products Because Pain is Not a Druggable Disease
FREDERICK, MD, USA, January 9, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today the publication of feature article The Case for Over-the-Counter Shortwave Therapy: Safe and Effective Devices for Pain Management in the peer reviewed journal Pain Management (http://www.futuremedicine.com/doi/full/10.2217/pmt.13.60). The current methods of drug-based analgesia are often […]
View PostBioElectronics’ RecoveryRx® and Smart Insole™ are Now Available in Austria
30 to 60% of Patients Still Have Chronic Pain Two Months After Surgery FREDERICK, MD, USA, November 19, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Biomax, Inc. and One Globe Biotechnology LLC have joined forces with Healthcare24 (www.healthcare24.at) to exclusively distribute RecoveryRx® and Smart Insole™ […]
View PostBioElectronics Appoints D.E.N. Medical as Distributor for Benelux Countries
RecoveryRx® Therapy Is Reducing Post-surgical Pain and Drug Use in a Global Market of 234 Million Surgeries Annually FREDERICK, MD, USA, October 31, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that it has signed D.E.N. Medical (www.denmedical.eu) as a distributor of RecoveryRx® Therapy in the Benelux […]
View PostBioElectronics Expands Italian Distribution
Success In Post-Surgical Market Drives Expansion Into Musculoskeletal And Menstrual Pain Markets FREDERICK, MD, USA, August 6, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that it has expanded its distribution in Italy with its current distributor, Biomax by adding its musculoskeletal and menstrual pain products. Biomax, […]
View Post- 1
- 2